Calnex Solutions PLC Director/PDMR Dealing

RNS Number : 2371H

Calnex Solutions PLC

08 October 2024

 

8 October 2024

Calnex Solutions plc

(the "Company")

Director / PDMR Dealing

Calnex Solutions plc (AIM: CLX), an established provided of test and measurement solutions for the global telecommunications sector, confirms the following transactions in the Company's ordinary shares.

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

1	Details of PDMR/person closely associated with them ("PCA")
1.1	Name	Graeme Bissett
1.2	Position/Status	Non-Executive Director
1.3	Initial notification / amendment	Initial notification
2	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
2.1	Name	Calnex Solutions plc
2.2	LEI	213800GY6TURGL3HYT04
3	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
3.1	Description of the financial instrument Identification code	Ordinary shares of 0.125 pence each GB00BMBK7016
3.2	Nature of the transaction	Purchase of Ordinary Shares
3.3	Price(s) and volume(s)	Price(s) Volume(s) £ 0.50889 39,299
3.4	Aggregated information ·              Aggregated volume ·              Price	39,299   £19,998.87
3.5	Date of the transaction	4th October 2024
3.6	Place of the transaction	London Stock Exchange (AIM:CLX)

 

For more information, please contact:

Calnex Solutions plc	Via Alma
Tommy Cook, Chief Executive Officer Ashleigh Greenan, Chief Financial Officer
Cavendish Capital Markets Limited - NOMAD	[phone]
Derrick Lee, Peter Lynch
Alma	+ 44(0) 20 3405 0213
Caroline Forde, Joe Pederzolli, Emma Thompson

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHUBOVRSSURRAA